BrightInsight is a global platform and services provider focused on regulated digital health solutions for biopharma and medtech, helping life sciences companies build, scale, and optimize digital offerings such as companion apps, SaMD, and healthcare provider interfaces. The company emphasizes delivering tangible clinical and business ROI through its platform across therapeutic areas including cardiovascular, diabetes, gene therapy, immunology, mental health and neurology, oncology, rare diseases, and respiratory. Headquartered in the United States with a global footprint, BrightInsight positions itself as a trusted partner for regulatory-compliant digital health initiatives and data-driven insights.
No recent deals for this company.